Current and emerging treatments for the management of osteogenesis imperfecta

References

• RauchFGlorieuxFHOsteogenesis imperfectaLancet20043631377138515110498
   PubMed Web of Science ®Google Scholar
• CheungMSGlorieuxFHOsteogenesis Imperfecta: update on presentation and managementRev Endocr Metab Disord2008915316018404382
   PubMed Web of Science ®Google Scholar
• MariniJCCabralWABarnesAMNull mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfectaCell Tissue Res20103391597019862557
   PubMed Web of Science ®Google Scholar
• RauchFLalicLRoughleyPGlorieuxFHRelationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfectaJ Bone Miner Res20099999999A130
   Google Scholar
• SillenceDOSennADanksDMGenetic heterogeneity in osteogenesis imperfectaJ Med Genet19791610116458828
   PubMed Web of Science ®Google Scholar
• van DijkFSPalsGvan RijnRRNikkelsPGCobbenJMClassification of osteogenesis imperfecta revisitedEur J Med Genet20105311519878741
   PubMed Web of Science ®Google Scholar
• BarnesAMCarterEMCabralWALack of cyclophilin b in osteogenesis imperfecta with normal collagen foldingN Engl J Med201036252152820089953
   PubMed Web of Science ®Google Scholar
• ByersPHKrakowDNunesMEPepinMGenetic evaluation of suspected osteogenesis imperfecta (OI)Genet Med2006838338816778601
   PubMed Web of Science ®Google Scholar
• MariniJCForlinoACabralWAConsortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycansHum Mutat20072820922117078022
   PubMed Web of Science ®Google Scholar
• VenturiGTedeschiEMottesMOsteogenesis imperfecta: clinical, biochemical and molecular findingsClin Genet20067013113916879195
   PubMed Web of Science ®Google Scholar
• BarnesAMChangWMorelloRDeficiency of cartilage – associated protein in recessive lethal osteogenesis imperfectaN Engl J Med20063552757276417192541
   PubMed Web of Science ®Google Scholar
• MorelloRBertinTKChenYCRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfectaCell200612729130417055431
   PubMed Web of Science ®Google Scholar
• BaldridgeDSchwarzeUMorelloRCRTAP and LEPRE1 mutations in recessive osteogenesis imperfectaHum Mutat2008291435144218566967
   PubMed Web of Science ®Google Scholar
• WillaertAMalfaitFSymoensSRecessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl-3-hydroxylationJ Med Genet20094623324119088120
   PubMed Web of Science ®Google Scholar
• van DijkFSNesbittIMZwikstraEHPPIB mutations cause severe osteogenesis imperfectaAm J Hum Genet20098552152719781681
   PubMed Web of Science ®Google Scholar
• ChristiansenHESchwarzeUPyottSMHomozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive Osteogenesis ImperfectaAm J Hum Genet20108638939820188343
   PubMed Web of Science ®Google Scholar
• AntoniazziFMottesMFraschiniPBrunelliPCTatoLOsteogenesis imperfecta: practical treatment guidelinesPaediatr Drugs2000246548811127846
   PubMedGoogle Scholar
• RauchFGlorieuxFHOsteogenesis imperfecta, current and future medical treatmentAm J Med Genet C Semin Med Genet2005139C313716278881
   PubMed Web of Science ®Google Scholar
• GlorieuxFHTreatment of osteogenesis imperfecta: who, why, whatHorm Res20076881118174695
   PubMedGoogle Scholar
• MillerMEHangartnerTNTemporary brittle bone disease: association with decreased fetal movement and osteopeniaCalcif Tissue Int1999641371439914321
   PubMed Web of Science ®Google Scholar
• SmithROsteogenesis imperfecta, non – accidental injury, and temporary brittle bone diseaseArch Dis Child1995721691717702388
   PubMed Web of Science ®Google Scholar
• MooreMSMinchCMKruseRWHarckeHTJacobsonLTaylorAThe role of dual energy x-ray absorptiometry in aiding the diagnosis of pediatric osteogenesis imperfectaAm J Orthop1998277977809880097
   PubMedGoogle Scholar
• DavieMWJHaddawayMJBone mineral content and density in healthy subjects and in osteogenesis imperfectaArch Dis Child1994703313348185368
   PubMed Web of Science ®Google Scholar
• RoschgerPPaschalisEPFratzlPKlaushoferKBone mineralization density distribution in health and diseaseBone20084245646618096457
   PubMed Web of Science ®Google Scholar
• SteinerRDPepinMByersPHStudies of collagen synthesis and structure in the differentiation of child abuse from osteogenesis imperfectaJ Pediatr19961285425478618190
   PubMed Web of Science ®Google Scholar
• van BrusselMTakkenTUiterwaalCSPhysical training in children with osteogenesis imperfectaJ Pediatr200815211111618154911
   PubMed Web of Science ®Google Scholar
• SmithRPhillipsAJOsteoporosis during pregnancy and its managementScand J Rheumatol1998107S6667
   Google Scholar
• MalmgrenBNorgrenSDental aberrations in children and adolescents with osteogenesis imperfectaActa Odontol Scand200260657112020117
   PubMed Web of Science ®Google Scholar
• HuberMAOsteogenesis imperfectaOral Surg Oral Med Oral Pathol Oral Radiol Endod200710331432017223585
   PubMed Web of Science ®Google Scholar
• SaevesRLande WekreLOral findings in adults with osteogenesis imperfectaSpec Care Dentist20092910210819284510
   PubMedGoogle Scholar
• PillionJPShapiroJAudiological findings in osteogenesis imperfectaJ Am Acad Audiol20081959560119323351
   PubMed Web of Science ®Google Scholar
• VincentRGratacapBOatesJSperlingNMStapedotomy in osteogenesis imperfecta: a prospective study of 23 consecutive casesOtol Neurotol20052685986516151329
   PubMed Web of Science ®Google Scholar
• SainzMGarcía-ValdecasasJBallesterosJMSurgical options for hearing loss in patients with osteogenesis imperfectaActa Otorrinolaringol Esp20096012613019401080
   PubMedGoogle Scholar
• GarretsenTJCremersCWStapes surgery in osteogenesis imperfecta: analysis of postoperative hearing lossAnn Otol Rhinol Laryngol19911001201301992898
   PubMed Web of Science ®Google Scholar
• RotteveelLJBeynonAJMensLHSnikAFMulderJJMylanusEACochlear implantation in 3 patients with osteogenesis imperfecta: imaging, surgery and programming issuesAudiol Neurootol200813738518057871
   PubMed Web of Science ®Google Scholar
• ShapiroJRSponsellorPDOsteogenesis imperfecta: questions and answersCurr Opin Pediatr20092170971619907330
   PubMed Web of Science ®Google Scholar
• LundAMHansenMKollerupGJuulATeisnerBSkovbyFCollagen – derived markers of bone metabolism in osteogenesis imperfectaActa Paediatr199887113111379846914
   PubMed Web of Science ®Google Scholar
• EngelbertRHPruijsHEBeemerFAHeldersPOsteogenesis imperfecta in childhood: treatment strategiesArch Phys Med Rehabil199879159015949862306
   PubMed Web of Science ®Google Scholar
• RussellDJRosenbaumPLAveryLMLaneMGross motor function measure (GMFM-66 and GMFM-88) User’s Manual1st EditionLondon, UnitedMac Keith Press2002
   Google Scholar
• MsallMEDiGaudioKDuffyLCLaForestSBraunSGrangerCVWeeFIM. Normative sample of an instrument for tracking functional independence in childrenClin Pediatr Phila1994334314387955782
   PubMed Web of Science ®Google Scholar
• BleckEENon operative treatment of osteogenesis imperfecta: orthotic and mobility managementClin Orth Rel Res1981159111122
   PubMedGoogle Scholar
• BinderHConwayAGerberLHRehabilitation approaches to children with osteogenesis imperfecta: a ten-year experienceArch Phys Med Rehabil1993743863908466420
   PubMed Web of Science ®Google Scholar
• GerberLHBinderHBerryREffects of withdrawal of bracing in matched pairs of children with osteogenesis imperfectaArch Phys Med Rehab1998794651
   PubMed Web of Science ®Google Scholar
• BrunelliPCFredianiPSurgical treatment of the deformities of the long bones in severe osteogenesis imperfectaAnn NY Acad Sci19885431701793214050
   PubMedGoogle Scholar
• KocherMSShapiroFOsteogenesis imperfectaJ Am Acad Orthop Surg199862252369682085
   PubMedGoogle Scholar
• EspositoPPlotkinHSurgical treatment of osteogenesis imperfecta: current conceptsCurr Opin Pediatr200820525718197039
   PubMed Web of Science ®Google Scholar
• GarganMFWisbeachAFixsenJAHumeral roding in osteogenesis imperfectaJ Pediatr Orthop1996167197228906640
   PubMed Web of Science ®Google Scholar
• PelusoACerulloMMalignant hyperthermia susceptibility in patients with osteogenesis imperfectaPaediatr Anaesth199553983998597980
   PubMedGoogle Scholar
• BencaJHoganKMalignant hyperthermia, coexisting disorders, and enzymopathies: risks and management optionsAnesth Analg20091091049105319762731
   PubMed Web of Science ®Google Scholar
• FraschiniPMadernaPCimolinVCrivelliniMGalliMGait analysis and energy consumption evaluation in subjects affected by Osteogenesis Imperfecta10th International Conference on Osteogenesis Imperfecta2008 Oct 15–18Ghent, Belgium2008
   Google Scholar
• McHaleKATenutaJJTosiLLMcKayDWPercutaneous intramedullary fixation of long bone deformity in severe osteogenesis imperfectaClin Orthop19943052422488050236
   PubMedGoogle Scholar
• JeroschJMazzottiITomasevicMComplications after treatment of patients with osteogenesis imperfecta with a Bailey – Dubow rodArch Orthop Trauma Surg19981172402459581251
   PubMed Web of Science ®Google Scholar
• ZiontsLEEbramzadehEStottNSComplications in the use of the Bailey – Dubow extensible nailClin Orthop19983481861959553552
   PubMedGoogle Scholar
• NicholasRWJamesPTelescoping intramedullary stabilization of the lower extremities for severe osteogenesis imperfectaJ Pediatr Orthop1990102192232312705
   PubMed Web of Science ®Google Scholar
• LuhmannSJSheridanJJCapelliAMSchoeneckerPLManagement of lower – extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: a 20-year experienceJ Pediatr Orthop19981888949449108
   PubMed Web of Science ®Google Scholar
• El-AdlGKhalilMAEnanAMostafaMFEl-LakkanyMRTelescoping versus non-telescoping rods in the treatment of osteogenesis imperfectaActa Orthop Belg20097520020819492559
   PubMed Web of Science ®Google Scholar
• EngelbertRHHeldersPJKeessenWPruijsHEHGooskensRHJMIntramedullary roding in type III osteogenesis imperfecta. Effects on neuromotor development in 10 childrenActa Orthop Scand1995663613647676827
   PubMed Web of Science ®Google Scholar
• GerberLHBinderHBerryREffects of withdrawal of bracing in matched pairs of children with osteogenesis imperfectaArch Phys Med Rehabil19987946519440417
   PubMed Web of Science ®Google Scholar
• BinderHConwayAHasonSComprehensive rehabilitation of the child with osteogenesis imperfectaAm J Med Genet1993452652698456816
   PubMed Web of Science ®Google Scholar
• HanscomDABloomBAThe spine in osteogenesis imperfectaOrthop Clin North Am1988194494583357690
   PubMed Web of Science ®Google Scholar
• ColeWGEarly surgical management of severe forms of osteogenesis imperfectaAm J Med Genet1993452702748456817
   PubMed Web of Science ®Google Scholar
• TopouchianVFinidoriGGlorionCPadovaniJPPouliquenJCPosterior spinal fusion for kypho – scoliosis associated with osteogenesis imperfecta: long term resultsRev Chir Orthop Reparatrice Appar Mot20049052553215672919
   PubMedGoogle Scholar
• WangTGYangGFAlbaAChronic ventilator use in osteogenesis imperfecta congenita with basilar impression: a case reportArch Phys Med Rehabil1994756997028002773
   PubMed Web of Science ®Google Scholar
• SawinPDMenezesAHBasilar invagination in osteogenesis imperfecta and related osteochondrodysplasias: medical and surgical managementJ Neurosurg1997869509609171173
   PubMed Web of Science ®Google Scholar
• JanusGJFinidoriGEngelbertRHPouliquenMPruijsJEOperative treatment of severe scoliosis in osteogenesis imperfecta: results of 20 patients after halo traction and posterior spondylodesis with instrumentationEur Spine J2000948649111189916
   PubMed Web of Science ®Google Scholar
• NoskeDPvan RoyenBJBronJLVandertopWPBasilar impression in osteogenesis imperfecta: can it be treated with halotraction and posterior fusion?Acta Neurochir200614813011305
   PubMed Web of Science ®Google Scholar
• ChevrelGMeunierPJAre drugs helpful in adults with osteogenesis imperfecta?Rev Rhum Engl Ed1997642832869190000
   PubMedGoogle Scholar
• AlbrightJASystemic treatment of osteogenesis imperfectaClin Orthop198115988967285474
   PubMed Web of Science ®Google Scholar
• PedersenUCharlesPHansenHHElbrøndOLack of effects of human calcitonin in osteogenesis imperfectaActa Orthop Scand1985562602644036580
   PubMed Web of Science ®Google Scholar
• NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1–34) on fractures and bone mineral density in post-menopausal women with osteoporosisN Eng J Med200134414341441
   PubMed Web of Science ®Google Scholar
• VahleJLSatoMLongGGSkeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1–34) for 2 years and relevance to human safetyToxicol Path20023031232112051548
   PubMed Web of Science ®Google Scholar
• ChengMCubertRMackSOsteogenesis imperfecta: pregnancy characteristics, mode of delivery, and neonatal outcome [abstract 0–23]7th International Conference on Osteogenesis Imperfecta1999 Aug 29–Sep 1Montreal, Canada1999
   Google Scholar
• CabralWAMariniJCHigh proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfectaAm J Hum Genet20047475276015024692
   PubMed Web of Science ®Google Scholar
• HorwitzEMProckopDJGordonPLClinical responses to bone marrow transplantation in children with severe osteogenesis imperfectaBlood2001971227123111222364
   PubMed Web of Science ®Google Scholar
• HorwitzEMProckopDJFitzpatrickLATransplantability and therapeutic effects of bone marrow – derived mesenchymal cells in children with osteogenesis imperfectaNat Med1999530931310086387
   PubMed Web of Science ®Google Scholar
• HorwitzEMGordonPLKooWKIsolated allogeneic bone marrow – derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of boneProc Natl Acad Sci2002998932893712084934
   PubMed Web of Science ®Google Scholar
• HorwitzEMDominiciMHow do mesenchymal stromal cells exert their therapeutic benefit?Cytotherapy20081077177419089685
   PubMed Web of Science ®Google Scholar
• Le BlancKGotherstromCRingdenOFetal mesenchymal stem – cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfectaTransplantation2005791607161415940052
   PubMed Web of Science ®Google Scholar
• RussellRGBisphosphonates: mode of action and pharmacologyPediatrics2007119S150S16217332236
   PubMed Web of Science ®Google Scholar
• MunnsCFRauchFTraversRGlorieuxFHEffects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcomeJ Bone Miner Res2005201235124315940378
   PubMed Web of Science ®Google Scholar
• FleischHBisphosphonates: mechanisms of actionEndocr Rev199819801009494781
   PubMed Web of Science ®Google Scholar
• AdamiSZamberlanNAdverse effects of bisphosphonates: a comparative reviewDrug Safe199614158170
   PubMed Web of Science ®Google Scholar
• BrumsenCHamdyNAPapapoulosSELong-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosisMedicine1997762662839279333
   PubMed Web of Science ®Google Scholar
• FleischHBisphosphonates in osteoporosisEur Spine J200312S142S14613680318
   PubMed Web of Science ®Google Scholar
• WardLTriccoACPhuongPBisphosphonate therapy for children and adolescents with secondary osteoporosisCochrane Database Syst Rev20074CD00532417943849
   PubMed Web of Science ®Google Scholar
• AllgroveJBiphosphonatesArch Dis Child19977673759059169
   PubMed Web of Science ®Google Scholar
• DevogelaerJPMalghemJMaldagueBNagant de DeuxchaisnesCRadiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfectaSkeletal Radiol1987163603633629280
   PubMed Web of Science ®Google Scholar
• HuauxJPLokietekWI sAPD a promising drug in the treatment of severe osteogenesis imperfecta?J Pediatr Orthop1988871723335625
   PubMed Web of Science ®Google Scholar
• Landsmeer-BekerEAMassaGGMaaswinkel-MooyPDvan de KampJJPapapoulosSETreatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate)Eur J Pediatr19971567927949365071
   PubMed Web of Science ®Google Scholar
• SakkersRKokDEngelbertRSkeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo – controlled studyLancet20043631427143115121405
   PubMed Web of Science ®Google Scholar
• MaasaluKHavikoTMartsonATreatment of children with osteogenesis imperfecta in EstoniaActa Paediatrica20039245245512801112
   PubMed Web of Science ®Google Scholar
• GlorieuxFHRauchFWardLMAlendronate in the treatment of pediatric osteogenesis imperfectaJ Bone Miner Res200419S12
   Web of Science ®Google Scholar
• WilliamsCJSmithRABallRJWilkinsonHHypercalcaemia in osteogenesis imperfecta treated with pamidronateArch Dis Child1997761691709068314
   PubMed Web of Science ®Google Scholar
• ShawNJBisphosphonates in osteogenesis imperfectaArch Dis Child19977792939279168
   PubMed Web of Science ®Google Scholar
• BembiBParmaABottegaMIntravenous pamidronate treatment in osteogenesis imperfectaJ Pediatr19971316226259386671
   PubMed Web of Science ®Google Scholar
• FujiwaraIOgawaEIgarashiYOhbaMAsanumaAIntravenous pamidronate treatment in osteogenesis imperfectaEur J Pediatr19981572612629537501
   PubMed Web of Science ®Google Scholar
• GlorieuxFHBishopNJPlotkinHChabotGLanoueGTraversRCyclic administration of pamidronate in children with severe osteogenesis imperfectaN Engl J Med19983399479529753709
   PubMed Web of Science ®Google Scholar
• AstromESoderhallSBeneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArch Dis Childhood20028635636411970931
   PubMed Web of Science ®Google Scholar
• CheungMSGlorieuxFHRauchFIntravenous pamidronate in osteogenesis imperfecta type VIICalcif Tissue Int20098420320919137231
   PubMed Web of Science ®Google Scholar
• RauchFTraversRGlorieuxFHPamidronate in children with osteogenesis imperfecta: histomorphometric effects of long – term therapyJ Clin Endocrinol Metab20069151151616291701
   PubMed Web of Science ®Google Scholar
• LandCRauchFMunnsCFSahebjamSGlorieuxFHVertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatmentBone20063990190616730480
   PubMed Web of Science ®Google Scholar
• GattiDAntoniazziFPrizziRIntravenous neridronate in children with osteogenesis imperfecta: a randomized controlled studyJ Bone Miner Res20052075876315824848
   PubMed Web of Science ®Google Scholar
• AntoniazziFZamboniGLauriolaSDonadiLAdamiSTatòLEarly bisphosphonate treatment in infants with severe osteogenesis imperfectaJ Pediatr200614917417916887429
   PubMed Web of Science ®Google Scholar
• PhillipiCARemmingtonTSteinerRDBisphosphonate therapy for osteogenesis imperfectaCochrane Database Syst Rev20084CD00508818843680
   PubMed Web of Science ®Google Scholar
• PlotkinHRauchFBishopNJPamidronate treatment of severe osteogenesis imperfecta in children under 3 years of ageJ Clin Endocrinol Metab2000851846185010843163
   PubMed Web of Science ®Google Scholar
• RauchFCornibertSCheungMGlorieuxFHLong – bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfectaBone20074082182717223617
   PubMed Web of Science ®Google Scholar
• GlorieuxFHExperience with bisphosphonates in osteogenesis imperfectaPediatrics2007119S163S16517332237
   PubMed Web of Science ®Google Scholar
• BrownJJZacharinMRSafety and efficacy of intravenous zoledronic acid in paediatric osteoporosisJ Pediatr Endocrinol Metab200922556319344075
   PubMed Web of Science ®Google Scholar
• AntoniazziFZamboniGBertoldoFLauriolaSTatòLBone development during GH and GnRH analog treatmentEur J Endocrinol2004151S47S5415339244
   PubMed Web of Science ®Google Scholar
• ErnstMRodanGAIncreased activity of insulin – like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3Endocrinology19901278078142164921
   PubMed Web of Science ®Google Scholar
• McCarthyTLCentrellaMCanalisERegulatory effects of insulin – like growth factors I and II on bone collagen synthesis in rat calvarial culturesEndocrinology19891243013092909370
   PubMed Web of Science ®Google Scholar
• HockJMCentrellaMCanalisEInsulin – like growth factor I has independent effects on bone matrix formation and cell replicationEndocrinology19881222542603335207
   PubMed Web of Science ®Google Scholar
• WergedalJEMohanSLundyMBaylinkDJSkeletal growth factor and other factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cellsJ Bone Miner Res199051791862156409
   PubMed Web of Science ®Google Scholar
• KingDJarjouraDMcEwenHAAskewMJGrowth hormone injections improve bone quality in a mouse model of osteogenesis imperfectaJ Bone Miner Res20052098799315883639
   PubMed Web of Science ®Google Scholar
• KingDChaseJHaveyRMEffects of growth hormone transgene expression on vertebrae in a mouse model of osteogenesis imperfectaSpine2005301491149515990661
   PubMed Web of Science ®Google Scholar
• OhlssonCBengtssonBIsakssonOGPAndreassenTTSlootwegMCGrowth hormone and boneEndocrinol Rev1998195579
   PubMed Web of Science ®Google Scholar
• LundAMMullerJSkovbyFAnthropometry of patients with osteogenesis imperfectaArch Dis Child19998052452810332000
   PubMed Web of Science ®Google Scholar
• MariniJCBordenickSHeavnerGThe growth hormone and somatomedin axis in short children with osteogenesis imperfectaJ Clin Endocrinol Metab1993762512568421094
   PubMed Web of Science ®Google Scholar
• VetterUPontzBZaunerEBrennerRESprangerJOsteogenesis imperfecta: a clinical study of the first ten years of lifeCalcif Tissue Int19925036411739868
   PubMed Web of Science ®Google Scholar
• VieiraNEMariniJCHopkinsEAbramsSAYergeyALEffect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IVBone19992550150510511119
   PubMed Web of Science ®Google Scholar
• MariniJCHopkinsEGlorieuxFHPositive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagenJ Bone Miner Res20031823724312568401
   PubMed Web of Science ®Google Scholar
• KruseHPKuhlencordtFOn an attempt to treat primary and secondary osteoporosis with human growth hormoneHorm Metab Res197574884911213656
   PubMed Web of Science ®Google Scholar
• MariniJCHopkinsEReingCMGrowth hormone treatment trial of children with types III and IV osteogenesis imperfectaSixth International Conference on Osteogenesis Imperfecta1996 Sep 19–21Utrecht, The Netherlands
   Google Scholar
• SillenceDBriodyJAultJFactors which influence the efficacy of growth hormone in 15 children with osteogenesis imperfecta types I and IVSixth International Conference on Osteogenesis Imperfecta1996 Sep 19–21Utrecht, The Netherlands1996
   Google Scholar
• KodamaHKubotaKAbeTOsteogenesis imperfecta: are fractures and growth hormone treatment linked?J Pediatr19981325595609544925
   PubMed Web of Science ®Google Scholar
• AntoniazziFBertoldoFMottesMGrowth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesisJ Pediatr19961294324398804334
   PubMed Web of Science ®Google Scholar
• MariniJCGerberNLOsteogenesis imperfecta. Rehabilitation and prospects for gene therapyJAMA19972777467509042848
   PubMed Web of Science ®Google Scholar
• ProckopDJKivirikkoKICollagens: molecular biology, diseases, and potentials for therapyAnn Rev Biochem1995644034347574488
   PubMed Web of Science ®Google Scholar
• Millington-WardSMcMahonHPFarrarGJEmerging therapeutic approaches for osteogenesis imperfectaTrends Mol Med20051129930515949772
   PubMed Web of Science ®Google Scholar
• ChamberlainJRDeyleDRSchwarzeUGene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfectaMol Ther20081618719317955022
   PubMed Web of Science ®Google Scholar
• WangQMariniJCAntisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disordersJ Clin Invest1996974484548567966
   PubMed Web of Science ®Google Scholar
• GrassiGForlinoAMariniJCCleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutationspecific and shows competitive binding effectsNucleic Acids Res199725345134589254703
   PubMed Web of Science ®Google Scholar
• Millington-WardSMcMahonHPAllenDRNAi of COL1A1 in mesenchymal progenitor cellsEur J Hum Genet20041286486615241481
   PubMed Web of Science ®Google Scholar
• PereiraRFO’HaraMDLaptevAVMarrow stromal cells as a source of progenitor cells for non hematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfectaProc Natl Acad Sci U S A199895114211479448299
   PubMed Web of Science ®Google Scholar
• MariniJCOsteogenesis imperfecta calls for cautionNat Med1999546646710229207
   PubMedGoogle Scholar
• BishopNJOsteogenesis imperfecta calls for cautionNat Med1999546646710229208
   PubMedGoogle Scholar
• PanaroniCGioiaRLupiAIn utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfectaBlood200911445946819414862
   PubMed Web of Science ®Google Scholar